INEST,Inc. Logo

INEST,Inc.

Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.

7111 | T

Overview

Corporate Details

ISIN(s):
JP3104810001
LEI:
Country:
Japan
Address:
豊島区東池袋一丁目25番9号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INEST, Inc. is a holding company that provides marketing and solution support services for both corporate enterprises and individual consumers. The company's corporate business segment focuses on developing, selling, operating, and maintaining application service provider (ASP) solutions, with a particular emphasis on chain stores and restaurants. It also offers consulting and on-site human resources support. The individual business segment is primarily engaged in the sale of mobile devices, including smartphones and tablets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:38
Registration Form
確認書
Japanese 9.0 KB
2025-11-14 07:35
Interim Report
半期報告書-第4期(2025/04/01-2026/03/31)
Japanese 229.9 KB
2025-06-30 07:22
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 27.2 KB
2025-06-27 06:03
M&A Activity
臨時報告書
Japanese 32.6 KB
2025-06-25 10:08
Governance Information
内部統制報告書-第3期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-25 10:06
Registration Form
確認書
Japanese 8.7 KB
2025-06-25 10:05
Annual Report
有価証券報告書-第3期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2025-06-24 10:14
Post-Annual General Meeting Information
臨時報告書
Japanese 28.3 KB
2025-01-16 07:37
M&A Activity
臨時報告書
Japanese 20.1 KB
2024-11-14 07:57
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-11-14 07:55
Interim Report
半期報告書-第3期(2024/04/01-2025/03/31)
Japanese 232.6 KB
2024-06-28 07:14
Governance Information
内部統制報告書-第2期(2023/04/01-2024/03/31)
Japanese 23.1 KB
2024-06-28 07:14
Registration Form
確認書
Japanese 8.8 KB
2024-06-28 07:13
Registration Form
有価証券報告書-第2期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-06-27 08:46
Post-Annual General Meeting Information
臨時報告書
Japanese 25.3 KB

Automate Your Workflow. Get a real-time feed of all INEST,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INEST,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INEST,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.